A synergistic blend of highly orally bio-available BPC-157 with PEA and L-glutamine to deliver superior full body regeneration.


Or 4 fortnightly payments of $33.73 with Afterpay.

60 Capsules (30 Servings) 1 Month Supply

regenerate information

Joe Rogan, Ben Greenfield and Dave Asprey On BPC 157



A synergistic blend of highly orally bio-available BPC-157 with PEA and L-glutamine to deliver superior full body regeneration.


Each bottle contains 60 capsules; 30 serves.

Legal Disclaimer:
*This product is intended for research purposes only. All product
information available on the website is for educational purposes only.
Bodily introduction of any kind into humans is done at the person’s own
risk, and LVLUP Health assumes no responsibility for health outcomes,
good or bad that may result from ingestion or use. Use should be
supervised by a qualified healthcare professional.




- Enhances injury and wound recovery

- Heals the Gastro-Intestinal (GI) tract

- Stimulates blood vessel formation (angiogenesis)

- Upregulates Growth Hormone Receptors

- Enhances collagen production and formation

- Anti-Inflammatory

- Cytoprotective

-Modulates Nitric Oxide (NO)

- Reduces Neuroinflammation


- Anti Inflammatory

- Blocks mast cells degranulation (Antihistamine)

- Binding affinity for the CB1, CB2 and GPR55 cannabinoid receptors

- Reduces the expression of cyclooxygenase-2 (COX-2)

- Inhibits the release of histamine and TNF-alpha

- Relieves Pain


- Promotes enterocyte proliferation

- Regulates tight junction proteins

- Suppresses pro-inflammatory signaling pathways

- Protects cells against apoptosis and cellular stresses


Take two capsules per day at any time, or as directed by health professional.

Can be taken with or without food.

PEA (included in the product) is a fatty acid that in rare cases can some mild nausea for those with fat absorption issues and those without a gallbladder




Butler, R. J., Marchesi, S., Royer, T., & Davis, I. S. (2007).
Effective Therapy of Transected Quadriceps Muscle in Rat:Gastric
Pentadecapeptide BPC 157. Journal of Orthopaedic Research September,
25(June), 1121–1127.

Brcic, L., Brcic, I., Staresinic, M., Novinscak, T., Sikiric, P.,
& Seiwerth, S. (2009). Modulatory effect of gastric pentadecapeptide
BPC 157 on angiogenesis in muscle and tendon healing. Journal of
Physiology and Pharmacology : An Official Journal of the Polish
Physiological Society, 60 Suppl 7, 191–196.

Cerovecki, T., Bojanic, I., Brcic, L., Radic, B., Vukoja, I.,
Seiwerth, S., & Sikiric, P. (2010). Pentadecapeptide BPC 157 (PL
14736) improves ligament healing in the rat. Journal of Orthopaedic
Research, 28(9), 1155–1161.

Chang, C. H., Tsai, W. C., Hsu, Y. H., & Pang, J. H. S. (2014).
Pentadecapeptide bpc 157 enhances the growth hormone receptor expression
in tendon fibroblasts. Molecules, 19(11), 19066–19077.

Chang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., & Su Pang, J.
H. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon
healing involves tendon outgrowth, cell survival, and cell migration.
Journal of Applied Physiology, 110(3), 774–780.

Gjurasin, M., Miklic, P., Zupancic, B., Perovic, D., Zarkovic, K.,
Brcic, L., … Sikiric, P. (2010). Peptide therapy with pentadecapeptide
BPC 157 in traumatic nerve injury. Regulatory Peptides, 160(1–3), 33–41.

Gwyer, D., Wragg, N. M., & Wilson, S. L. (2019). Gastric
pentadecapeptide body protection compound BPC 157 and its role in
accelerating musculoskeletal soft tissue healing. Cell and Tissue
Research, 377(2), 153–159.

Perovic, D., Kolenc, D., Bilic, V., Somun, N., Drmic, D., Elabjer,
E., … Sikiric, P. (2019). Stable gastric pentadecapeptide BPC 157 can
improve the healing course of spinal cord injury and lead to functional
recovery in rats. Journal of Orthopaedic Surgery and Research, 14(1),

Pevec, D., Novinscak, T., Brcic, L., Sipos, K., Jukic, I.,
Staresinic, M., … Sikiric, P. (2010). Impact of pentadecapeptide BPC 157
on muscle healing impaired by systemic corticosteroid application.
Medical Science Monitor, 16(3), 81–88.

Seiwerth, S., Sikiric, P., Grabarevic, Z., Zoricic, I., Hanzevacki,
M., Ljubanovic, D., … Kolega, Z. (1997). BPC 157’s effect on healing.
Journal of Physiology Paris, 91(3–5), 173–178.

Sever, A. Z., Sever, M., Vidovic, T., Lojo, N., Kolenc, D., Vuletic,
L. B., … Sikiric, P. (2019). Stable gastric pentadecapeptide BPC 157 in
the therapy of the rats with bile duct ligation. European Journal of
Pharmacology, 847(January), 130–142.

Sikiric, P. (1999). The pharmacological properties of the novel peptide BPC 157 (PL-10). Inflammopharmacology, 7(1), 1–14. 

Sikiricc, P., Petek, M., Rucman, R., Seiwerth, S., Grabarevic, Z.,
Rotkvic, I., … Karakas, I. (1993). A new gastric juice peptide, BPC. An
overview of the stomach-stress-organoprotection hypothesis and
beneficial effects of BPC. Journal of Physiology – Paris, 87(5),

Sikiric, P., Seiwerth, S., Kolenc, D., Grgic Klinicka bolnica, T.,
Duh, S., Rucman, R., … Vlainic, J. (2018). Brain-gut Axis and
Pentadecapeptide BPC 157: Theoretical and Practical Implications Article
in DNA research: an international journal for rapid publication of
reports on genes and genomes · May 2016 CITATIONS 12 READS 793 Genetic
and epigenetic biomarkers of innate immunity in COPD and lung cancer
View project BPC 157

Staresinic, M., Sebecic, B., Patrlj, L., Jadrijevic, S., Suknaic, S.,
Perovic, D., … Sikiric, P. (2003). Gastric pentadecapeptide BPC 157
accelerates healing of transected rat Achilles tendon and in vitro
stimulates tendocytes growth. Journal of Orthopaedic Research, 21(6),